Patents by Inventor Ayaka Kotani

Ayaka Kotani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240158436
    Abstract: Disclosed is a method for producing a fusion protein in which an antibody and a lysosomal enzyme are fused. The method is a method for producing a fusion protein in which an antibody and a human lysosomal enzyme are fused, the method including: (a) culturing mammalian cells producing the fusion protein in a serum-free medium to secrete the fusion protein in a culture medium; (b) collecting a culture supernatant by removing the mammalian cells from the culture medium; and (c) purifying the fusion protein from the culture supernatant by using a column chromatography using a material to which a substance having affinity for the antibody is bound as a solid phase, an anion exchange column chromatography, a cation exchange column chromatography, and a size exclusion column chromatography.
    Type: Application
    Filed: March 8, 2022
    Publication date: May 16, 2024
    Applicant: JCR PHARMACEUTICALS CO., LTD.
    Inventors: Shinji Kakimoto, Tsuyoshi Fukui, Yukichi Hatano, Ayaka Kotani, Takuya Miura, Toshifumi Ishiguro
  • Publication number: 20240132566
    Abstract: Disclosed is a method for producing a fusion protein of human serum albumin and human growth hormone. The method comprises (a) a step of culturing a mammalian cell capable of producing the protein in a serum-free medium and causing the protein to be secreted into the culture fluid, (b) a step of collecting a culture supernatant by removing the mammalian cell from the culture fluid, and (c) a step of purifying the protein from the culture supernatant by using column chromatography using a material to which an antibody having an affinity for the protein is bound as a stationary phase, column chromatography using a material having an affinity for phosphate group as a stationary phase, cation exchange column chromatography, and size exclusion column chromatography.
    Type: Application
    Filed: October 15, 2020
    Publication date: April 25, 2024
    Applicant: JCR PHARMACEUTICALS CO., LTD.
    Inventors: Shinji KAKIMOTO, Tsuyoshi FUKUI, Yukichi HATANO, Ayaka KOTANI, Ryota KATSUNO, Yuko OKADA
  • Patent number: 10557115
    Abstract: Provided are a novel medium for expressing glycoproteins by culturing cells and a method for producing glycoproteins by culturing cells in the medium. Further provided are a medium comprising uridine and N-acetyl-D-mannosamine for the use of expression of a glycoprotein by culturing cells and a method for producing glycoproteins by culturing cells in for medium.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: February 11, 2020
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventors: Miroslav Matev, Kenichi Takahashi, Shinji Kakimoto, Ayaka Kotani
  • Publication number: 20190352599
    Abstract: Provided are a novel medium for expressing glycoproteins by culturing cells and a method for producing glycoproteins by culturing cells in said medium. Further provided are a medium comprising uridine and N-acetyl-D-mannosamine for the use of expression of a glycoprotein by culturing cells and a method for producing glycoproteins by culturing cells in said medium.
    Type: Application
    Filed: March 26, 2019
    Publication date: November 21, 2019
    Applicant: JCR Pharmaceuticals Co., Ltd.
    Inventors: Miroslav MATEV, Kenichi Takahashi, Shinji Kakimoto, Ayaka Kotani
  • Patent number: 10273448
    Abstract: Provided are a novel medium for expressing glycoproteins by culturing cells and a method for producing glycoproteins by culturing cells in the medium. Further provided are a medium comprising uridine and N-acetyl-D-mannosamine for the use of expression of a glycoprotein by culturing cells and a method for producing glycoproteins by culturing cells in the medium.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: April 30, 2019
    Assignee: JCR PHARMACEUTICALS CO., LTD.
    Inventors: Miroslav Matev, Kenichi Takahashi, Shinji Kakimoto, Ayaka Kotani
  • Publication number: 20170073633
    Abstract: Provided are a novel medium for expressing glycoproteins by culturing cells and a method for producing glycoproteins by culturing cells in said medium. Further provided are a medium comprising uridine and N-acethyl-D-mannosamine for the use of expression of a glycoprotein by culturing cells and a method for producing glycoproteins by culturing cells in said medium.
    Type: Application
    Filed: November 30, 2016
    Publication date: March 16, 2017
    Applicant: JCR Pharmaceuticals Co., Ltd.
    Inventors: Miroslav MATEV, Kenichi Takahashi, Shinji Kakimoto, Ayaka Kotani